Latest tumor Stories
TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized
Preclinical Data Indicates Targeting Hyaluronan in the Tumor Stroma May Offer A New Approach to Pancreatic Cancer Treatment SAN DIEGO, Oct.
DelMar Pharmaceuticals Presents Data at AACR's New Horizons in Cancer Research Conference in Shanghai, China VANCOUVER, British Columbia, MENLO PARK, Calif. and SHANGHAI, Oct.
Program Funded by the National Cancer Institute (NCI) CHARLOTTESVILLE, Va., Oct.
LEWISVILLE, Texas and CLEVELAND, Oct.
Results, Published in Clinical Genitourinary Cancer, Offer Key Insights and Potential New Treatment Strategies for Patient Population with Limited Drug Options IRVING, Texas, Oct.
Completion of Enrollment Expected in 2015; Progression-Free Survival Data Expected in mid-2016 LOS ANGELES, Sept.
- Awarded phase II STTR grant of approximately $1.1 million from NIH to develop tumor activated prodrugs BOSTON, Sept.
ALBANY, New York, September 29, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Circulating Circulating Tumor Cells (CTCs)
Additional Study Focuses on the Detection and Quantitative Monitoring of EGFR Mutations in Lung Cancer Patients SAN DIEGO, Sept.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).